Clinical trial
Prospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
NCT04022031 is registered in ClinicalTrials.gov with Tianjin University of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
- Lead sponsor
- Tianjin University of Traditional Chinese Medicine
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2019
- Completion date
- September 1, 2022
- Enrollment
- 12,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic heart disease with angina nos